Characteristics | All patients (n = 24) | Group | ||
---|---|---|---|---|
A (n = 11) | B (n = 13) | P-value | ||
Age (y) | 48 ± 1.73 | 42.05 ± 9.46 | 53 ± 2.09 | 0.11 |
Gender | ||||
 Male (%) | 9/24 (37.50) | 1/11 (9.09) | 8/13 (61.54) | 0.013 |
 Female (%) | 15/24 (62.50) | 10/11 (90.91) | 5/13 (38.46) |  |
Duration from onset to hospitalization (d) | 5.5 (7) | 3 (5) | 6 (4) | 0.011 |
PSI | 0 (57.25) | 0 (44) | 45 (72.5) | 0.252 |
 I (%) | 16/24 (66.67) | 9/11 (81.82) | 7/13 (53.85) |  |
 II ≤70 (%) | 4/24 (16.67) | 1/11 (9.09) | 3/13 (23.08) |  |
 III 71–90 (%) | 3/24 (12.50) | 1/11 (9.09) | 2/13 (15.38) |  |
 IV 91–131 (%) | 1/24 (4.17) | 0/11 (0) | 1/13 (7.69) |  |
 V > 130 (%) | 0/37 (0) | 0/19 (0) | 0/18 (0) |  |
Underlying disease | ||||
 Any (%) | 6/24 (25.00) | 0/11 (0) | 6/13 (46.15) | 0.016 |
 Hypertension (%) | 2/24 (8.33) | 0/11 (0) | 2/13 (15.38) | 0.482 |
 Coronary heart disease (%) | 2/24 (8.33) | 0/11 (0) | 2/13 (15.38) | 0.482 |
 Diabetes (%) | 1/24 (4.17) | 0/11 (0) | 1/13 (7.69) | 1 |
 Cirrhosis, liver cancer (%) | 1/24 (4.17) | 0/11 (0) | 1/13 (7.69) | 1 |
Symptoms | ||||
 Asymptomatic (%) | 7/24 (29.17) | 6/11 (54.55) | 1/13 (7.69) | 0.023 |
 Fever (%) | 15/24 (62.50) | 5/11 (45.45) | 10/13 (76.92) | 0.206 |
 Fatigue (%) | 5/24 (20.83) | 1/11 (9.09) | 4/13 (30.77) | 0.327 |
 Headache (%) | 1/24 (4.17) | 1/11 (9.09) | 0/13 (0) | 0.458 |
 Nasal congestion (%) | 2/24 (8.33) | 0/11 (0) | 2/13 (15.38) | 0.482 |
 Sore throat (%) | 6/24 (25.00) | 2/11 (18.18) | 4/13 (30.77) | 0.649 |
 Cough (%) | 17/24 (70.83) | 8/11 (72.73) | 9/13 (69.23) | 1 |
 Hemoptysis (%) | 1/24 (4.17) | 0/11 (0) | 1/13 (7.69) | 1 |
 Shortness of breath (%) | 10/24 (41.67) | 3/11 (27.27) | 7/13 (53.85) | 0.240 |
 Vomiting or diarrhea (%) | 6/24 (25.00) | 3/11 (27.27) | 3/13 (23.08) | 1 |
 Pain in a muscle or joint (%) | 1/24 (4.17) | 0/11 (0) | 1/13 (7.69) | 1 |
Laboratory findings | ||||
 WBC < 4.0 × 109/L (%) | 7/24 (29.17) | 3/11 (27.27) | 4/13 (30.77) | 1 |
 L < 1.1 × 109/L (%) | 14/24 (58.33) | 6/11 (54.55) | 8/13 (61.54) | 1 |
 L ≤ 0.6 × 109/L (%) | 7/14 (50.00) | 3/6 (50.0) | 4/8 (50.00) | 1 |
 SAA > 10 mg/L (%) | 15/24 (62.50) | 5/11 (45.45) | 10/13 (76.92) | 0.206 |
 CRP > 5 mg/L (%) | 12/24 (50.00) | 3/11 (27.27) | 9/13 (69.23) | 0.1 |
 PCT > 0.5 ng/ml (%) | 2/24 (8.33) | 2/11 (18.18) | 0/13 (0) | 0.199 |
 LDH > 250 U/L (%) | 5/24 (20.83) | 1/11 (9.09) | 4/13 (30.77) | 0.327 |
 Alb < 40 g/L (%) | 17/24 (70.83) | 8/11 (72.73) | 9/13 (69.23) | 1 |
 AST > 40 U/L (%) | 2/24 (8.33) | 1/11 (9.09) | 1/13 (7.69) | 1 |
 ALT > 40 U/L (%) | 1/24 (4.17) | 1/11 (9.09) | 0/13 (0) | 0.458 |
 TBL > 17.1 mmol/L (%) | 9/24 (37.50) | 3/11 (27.27) | 6/13 (46.15) | 0.423 |
 D-dimer > 0.5 mg/L (%) | 6/24 (25.00) | 3/11 (27.27) | 3/13 (23.08) | 1 |
 Fib > 4 g/L (%) | 6/24 (25.00) | 3/11 (27.27) | 3/13 (23.08) | 1 |
 ESR ≥20 mm/h (%) | 18/24 (75.00) | 8/11 (72.73) | 10/13 (76.92) | 1 |
Chest CT findings | ||||
Pneumonia (%) | 24/24 (100) | 11/11 (100) | 13/13 (100) | – |
 Bilateral infiltration (%) | 18/24 (75.00) | 7/11 (63.64) | 11/13 (84.62) | 0.357 |
 Unilateral infiltration (%) | 6/24 (25.00) | 4/11 (36.36) | 2/13 (15.38) |  |